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Abstract
Background: People with cardiac disease and type 2 diabetes have higher hospital readmission rates (22%)
compared to those without diabetes (6%). Self-management is an effective approach to achieve better health
outcomes; however there is a lack of specifically designed programs for patients with these dual conditions. This
project aims to extend the development and pilot test of a Cardiac-Diabetes Self-Management Program
incorporating user-friendly technologies and the preparation of lay personnel to provide follow-up support.
Methods/Design: A randomised controlled trial will be used to explore the feasibility and acceptability of the
Cardiac-Diabetes Self-Management Program incorporating DVD case studies and trained peers to provide follow-up
support by telephone and text-messaging. A total of 30 cardiac patients with type 2 diabetes will be randomised,
either to the usual care group, or to the intervention group. Participants in the intervention group will received the
Cardiac-Diabetes Self-Management Program in addition to their usual care. The intervention consists of three face-
to-face sessions as well as telephone and text-messaging follow up. The face-to-face sessions will be provided by a
trained Research Nurse, commencing in the Coronary Care Unit, and continuing after discharge by trained peers.
Peers will follow up patients for up to one month after discharge using text messages and telephone support.
Data collection will be conducted at baseline (Time 1) and at one month (Time 2). The primary outcomes include
self-efficacy, self-care behaviour and knowledge, measured by well established reliable tools.
Discussion: This paper presents the study protocol of a randomised controlled trial to pilot evaluates a Cardiac-
Diabetes Self-Management program, and the feasibility of incorporating peers in the follow-ups. Results of this
study will provide directions for using such mode in delivering a self-management program for patients with both
cardiac condition and diabetes. Furthermore, it will provide valuable information of refinement of the intervention
program.
Trial Registration NumberACTRN12611000086965
Background
Cardiac disease and diabetes are the most prevalent
chronic diseases in the Australian population. The num-
ber of people with diabetes is estimated to increase
from 171 million in 2000 to 366 million by 2030 [1,2].
The prevalence of diabetes for Australians aged 25 or
over in 1999-2000 was 7.4% (more than 1 in 14 people)
and the average age of people with diabetes is getting
younger [3]. In 2000-2003, it is reported that 6.6% of
Australians aged 18 years and over had diabetes [3].
Australia’s Health 2008 confirmed people diagnosed
with type 2 diabetes are more vulnerable to cardiovascu-
lar complications, and are at greater risk of further car-
diac events, leading to poor health-related quality of life
[3]. People with diabetes were reported to rate their
health three times lower than those without diabetes
[3,4]. The direct costs of treating type 2 diabetes and its
related complications is estimated to reach between
$213-396 billion a year globally by 2025, which is as
high as 40 percent of some countries’ health care bud-
gets [5-9]. Therefore, reducing the risk of diabetes and
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its associated cardiac complications is vitally important
not only from a personal, but also an economic
perspective.
Two previous studies undertaken by the first two
authors provided the basis for developing the initial Car-
diac-Diabetes Self-Management Program (CDSMP). An
exploratory study of the demographic characteristics
and incidence of critical cardiac admission for patients
with type 2 diabetes over a four-year period indicated
15% of all Coronary Care Unit (CCU) patients had a
previous diagnosis of type 2 diabetes, and 22% of these
patients were readmitted to hospital within 28 days
compared to only 6% of CCU patients without diabetes
[10]. A second study using a qualitative interpretative
approach to gain in-depth understanding of the needs
and experiences of this at-risk group of patients, found
four main themes of confidence in self, confidence in
health professionals, feelings of hopelessness and fatigue
were related to managing their conditions following dis-
charge [11]. These findings highlighted the complexity
for patients with these two conditions in undertaking
self-management. Both studies were invaluable in the
development of a new self-management program, the
CDSMP, which was based on self-efficacy construct [12].
The self-efficacy construct is based on the effect of a
person’s belief in their abilities to successfully follow
through with planned actions and accomplish goals.
Furthermore, a person with high self-efficacy will tend
to set higher personal goals than someone with low self-
efficacy, who will have very little faith in his/ her ability
to achieve in the area in question [13].
Current literature supports the success of self-manage-
ment programs based on improving self-efficacy levels in
modifying lifestyles for different patient groups with
chronic diseases such as type 2 diabetes [14,15] and car-
diac disease [16]. Patients with type 2 diabetes who are
admitted to CCU following a critical cardiac event are
suddenly confronted with a number of life style rules
and advice in order to deal with their illnesses. Often
these rules and recommendations are presented sepa-
rately for each disease and not tailored to the needs of
patients with both diabetes and a cardiac condition.
Furthermore, such guidance is given by professionals
who might not have experienced any of the challenges
these patients now face.
Having peer support during this initial period is very
valuable. A recent World Health Organisation (WHO)
consultation on peer support programs indicated these
were promising and presented recommendations for
developing and evaluating such programs [17]. A peer
support person is someone who has experienced similar
conditions, been successful in managing their conditions
and is able to provide relevant and meaningful informa-
tion [18].
Although the benefits of peer support for improving
chronic illness self-management, including diabetes, to
achieve better health outcomes has been demonstrated
[18-22] there is limited evidence that self-management
programs provided by or incorporating peers have
improved psychological, or reduced health care utiliza-
tion [22,23]. Furthermore, no research has yet been
undertaken to evaluate the effectiveness of peer support
for patients with both type 2 diabetes and cardiac condi-
tions, nor has it been evaluated in different contexts
(hospital and community).
Aim
To develop and pilot test a Cardiac-Diabetes Self-Man-
agement Program (CDSMP) utilising peer support for
improving self-management for patients with both dia-
betes and cardiac conditions.
Objectives
• To further develop a CDSMP for patients with
type 2 diabetes following a critical cardiac event,
including the development of a DVD incorporating
stories from a range of case studies, and use of for-
mer patients (peers) to provide support in adopting
self-management strategies.
• To evaluate the feasibility and applicability of the
DVD and peer supported CDSMP.
Hypotheses
• Anticipated outcomes for the intervention group
when compared to the control group receiving usual
care will include:
• Higher self-management practice scores;
• Higher self-efficacy levels;
• Higher knowledge scores.
Methods/Design
The pilot study using randomised controlled trial design
(parallel-group trial) within the participants’ usual health
care environment will be conducted in three distinct but
overlapping phases: (1) development of the training
package including the CDSMP materials and Digital
Video Disk (DVD), (2) peer selection and training, and
(3) intervention phase. These will each be described
below.
Phase 1: Development of the CDSMP
The intervention utilised in this project will be based on
the Cardiac Diabetes Self Management Program devel-
oped in earlier research by the first two authors [12]. It
will be modified according to feedback from its initial
trial, which included suggestions for adding a multimedia
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component; this will take the form of a DVD. The DVD
will be provided to participants in the intervention
group to assist them to apply strategies from the self-
efficacy model; it will take the form of narrative “real-
life” stories of people managing both diabetes and car-
diac conditions. A further addition to the program will
be the use of peers to provide follow-up support to
participants.
The CDSMP program consists of three face-to-face
sessions and telephone and text-messaging follow-up.
The face-to-face sessions will be provided by a trained
Research Nurse, and be conducted while the patients
are in CCU and continue as the patient makes the tran-
sition home after discharge. The participants will be tel-
ephoned 1 week after discharge home and 2 text-
messages will be sent a week after telephone follow up.
These will be conducted by the trained ‘peers’.
Reference Group
A reference group will be formed for the purposes of
informing and reviewing program materials. The panel
will consist of experts in the field (e.g. cardiologists, dia-
betes educators, cardiac rehabilitation coordinators) plus
the researchers. After agreeing to participate, panellists
will attend face-to-face meetings to establish the roles
and responsibilities of the panel, such as reviewing and
commenting on program development, including DVD
production, and to agree on acceptable methods of com-
munication. The panel will provide an important source
of guidance in the production of all educational materi-
als, in particular the DVD.
DVD Production
“Actors” in the DVD will be actual people dealing with
diabetes and cardiac conditions and discussions will be
held between these actors, the production team and
Chief Investigator to ensure understanding of individual
roles, as well as the DVD as a whole. Prior to produc-
tion, reference group members will be given the oppor-
tunity to review and comment on the DVD script. The
resulting DVD will be presented to the reference group
for final approval before its use within the CDSMP.
Phase 2: Peer Selection & Training
Selection and training of peer supporters is a crucial
component to this project; a peer supporter is someone
who has similar conditions, and can use their own
experience to provide information to others. The peer
support person can be very useful to others who are try-
ing to work out the best ways of managing their health
[18]. Potential peers, who are considered competent in
the management of their conditions will be identified by
the cardiologist and subsequently trained by the
researchers. To facilitate the training process, a detailed
peer training manual will be developed, also utilising
self-efficacy principles.
Phase 3: Intervention
Control group (group 1): Participants will receive usual
care, which consists of education provided in the CCU
and referral as necessary to the diabetes educator.
Intervention group (group 2): Participants will receive
usual care and a combination of CDSMP sessions in the
CCU, plus peer telephone and text follow-ups.
The CDSMP is designed to be administered on a one-
to-one basis and to commence in CCU by staff mem-
bers, then be followed up by trained peers via a tele-
phone call one week after discharge and text message
reminders from peers in weeks three and four. If a
patient is transferred to a ward before completing the
program, the hospital-based section of the CDSMP will
be continued on the ward by the trained research nurse.
As part of the program, the DVD based on incorpor-
ating stories from a range of case studies is developed
and will be provided to participants in the intervention
group to assist them with the application of strategies
from the Self-Efficacy Model.
Settings and locations
The study will be conducted in the Coronary Care Units
(CCU) at Mater Health Services, and followed up by tel-
ephone and text messages at participants’ homes in Bris-
bane, Australia.
Participants
Sample size
A total of 30 patients for 2 groups will be required. This
sample size of 10-15 per group is suggested by Hertzog
(2008) [19]. This number is calculated with an alpha of
0.05 and power of 0.9, thus 10 patients per group will
be required to detect any statistical differences. Allowing
20% attrition rate, 13 patients per group will be
required. Thus with an alpha of 0.05 and power of 0.9,
8 patients per group was required to detect any statisti-
cal differences.
Inclusion criteria
Participants who will be included:
• are males and females aged over 18 years who have
given their consent to participate in the study
• have had type 2 diabetes for at least one year and
have been admitted to the CCU with a critical car-
diac event in the study hospitals
• can read and converse in English
• are physically stabilised
• have a mobile phone
Exclusion criteria
• Potential participants will be excluded if they:
• are unable to read and speak English
• are transferred to another hospital.
• are on respiratory ventilation
• are unconscious
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Minority groups or people from non-English speaking
backgrounds (NESB) will be included unless they cannot
read and speak English. English is needed, as the materi-
als are in English. Programs for non-English speaking
patients will be developed in future projects.
Randomisation
Simple randomisation using a randomisation table
(computerised sequence generation) will be used. Allo-
cation will be concealed by using sealed, numbered, opa-
que envelopes to both control and intervention groups.
Data Collection
Primary and secondary outcomes: Primary outcomes
include self-efficacy, self-care behaviour and knowledge.
Secondary outcome is readmission rate within 28 days.
Baseline (Time 1): When patients’ physical condition
is stable they will be invited by a Research Assistant
(RA) to participate in the study. Following explanation
of the study, demographic and baseline data will be col-
lected for those giving informed consent.
One month follow-up (Time 2): A questionnaire will
be posted to participants at their discharge location,
after which the RA will telephone the participant and
collect data over the phone. Posting the questionnaire
first will facilitate data collection in the telephone inter-
view. This method has been used previously by a
research team member [24], resulting in a high response
rate (84%).
Measures
Data will be collected on primary outcomes of this
study: self-management practice, self-efficacy, knowledge
and secondary outcome: readmission rates.
Self-management practice
Data will be collected at Time 1 and Time 2, and will be
measured using the Summary of Diabetes Self-Care
Activities (SDSCA) [25]. The SDSCA comprises 11
items that measure patients’ adherence to self-manage-
ment activities such as diet, exercise, blood glucose test-
ing, foot care, and smoking status. The respondents will
be asked to rate each item using 0-7 scale, with 7 indi-
cating most adherence to each aspect, and 0 for non-
compliance. Permission to use this tool has been
granted by the authors.
Self-efficacy
Data will be collected at Time 1 and Time 2, and will be
measured using the Diabetes Management Self-Efficacy
Scale (DMSES) (Australian-English version) [26]. The
DMSES comprises 20 items that measure patients’ con-
fidence levels (self-efficacy) in managing their diabetes.
The respondents will be asked to rate each item using
0-10 scale, with 10 indicating the highest confidence
level, and 0 the lowest. This scale is designed to
measure the self-efficacy levels of patients with type 2
diabetes. A high internal consistency was demonstrated
by the Cronbach alpha coefficient of 0.9. Face validity
was established through consultation with diabetes edu-
cators and patients with type 2 diabetes, and convergent
validity was demonstrated by the significant correlations
between DMSES and the General Self-Efficacy Scale
(GSE). Permission to use this tool has been granted.
Knowledge
Data will be collected at Time 1 and Time 2, and will be
measured using Diabetes Knowledge Questions (DKQ)
[27]. The DKQ measures patients’ knowledge of diabetes
and cardiac conditions. Each item with a correct answer
scores one point; score ranges are therefore 0 to 8.
Cronbach alpha for DKQ is 0.7, indicating good internal
consistency [27]. In addition, this scale is brief and unli-
kely to cause a ‘response burden’; particularly as patients
who have diabetes and have had a cardiac condition
may become tired answering questions. Permission to
use this tool has been granted.
Readmission rate
Readmission rate will be collected at Time 2, and will be
ascertained from hospital records.
Procedure
The nominated RA will liaise with the Nurse Unit Man-
ager (NUM) of the CCU, to obtain a list of eligible par-
ticipants from the CCU Admission Book. The RA will
then approach the potential participants for their
informed consent and to collect baseline data. After
baseline data is collected, a computer-generated list of
random numbers produced by the researcher will then
be used to randomly assign participants to either the
control group or the intervention group (See Figure 1:
Overview of data collection). Patients are blinded to
receive either usual care or usual care and CDSMP,
however the RA who assisting with data analysis is not
blinded.
Control group (group 1): Participants will receive
usual care, which consists of education provided in the
CCU and referral as necessary to the diabetes educator.
Intervention group (group 2): Participants will receive
usual care and a combination of CDSMP sessions in the
CCU, plus peer telephone and text follow-ups. The
CDSMP was designed to be administered on a one-to-
one basis and to commence in CCU by staff members,
then be followed up by trained peers via a telephone
call one week after discharge and text message remin-
ders from peers in weeks three and four. If a patient is
transferred to a ward before completing the program,
the hospital-based section of the CDSMP will be contin-
ued on the ward by the trained research nurse.
As part of the program, the DVD based on incorpor-
ating stories from a range of case studies is developed
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and will be provided to participants in the intervention
group to assist them with the application of strategies
from the Self-Efficacy Model.
Data Analysis
Prior to undertaking statistical tests, the homogeneity of
the sample will be examined. Due to small samples size;
non-parametric statistical tests will be used to determine
the relationships and differences between disease and
demographic variables: Chi-square for categorical vari-
ables and Mann-Whitney U test for continuous vari-
ables. The Wilcoxon Signed Rank test will be used to
determine whether any changes in outcome variables
occurred within and between groups over time. Mann-
Whitney U test will be used to confirm whether there is
an interaction between time and group. All analyses will
be conducted using SPSS version 18 with a pre-defined
level of statistical significance at p < 0.05.
Ethical Considerations
Ethical approvals have been granted by the Mater
Health Services Human Research Ethics Committee and
Queensland University of Technology Human Research
Ethics Committee.
Informed consent: All participants will be volunteers
who will provide written consent, and will be free to
withdraw at any time. Confidentiality: No identifying
information will be kept with the data, which will be
analysed and stored on a secure network drive at the
university, protected by password and used only for the
purposes of this study. Only the researchers involved in
this study will have access to the data. While no infor-
mation about the project will be published in any form
that will allow any individual to be recognised; non-
identifiable results will be reported within the hospital
and in the literature.
This study protocol is now registered with the Austra-
lia and New Zealand Clinical Trials Registry (Trial
Number: ACTRN12611000086965).
Discussion
This protocol has provided information on planning and
pilot testing the feasibility of a peer-support based car-
diac-diabetes self-management program. This project
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Figure 1 Overview of Data Collection.
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aims to compare and evaluate transitional care interven-
tions in order to reduce readmission rates and emer-
gency health service visits by patients with diabetes and
a cardiac event, and to improve their health, and psy-
chosocial well-being. Additionally, this project seeks to
improve the uptake of appropriate self-management in
people with both diabetes and a cardiac condition, and
encourage maintenance of independence. The findings
of this pilot study will provide baseline knowledge for
undertaking a larger study to test the effectiveness of a
self-management program, which incorporates text mes-
saging and telephone follow-up by a peer support per-
son for patients with both diabetes and a cardiac
condition.
Limitations
The results of this pilot study will provide valuable
information of the feasibility and acceptability of the
peer-support based cardiac-diabetes self-management
program, and direction of power analysis for required
sample size for a larger study. However, staff variations
and trend of patients within participating study sites
may vary for a future full study. For example, patients’
self-care behaviour and self-efficacy levels may not be
consistent with pilot study. The research nurse trained
for this study is specialised in coronary care, which
could possibly lead to contamination associated with
delivering the program.
Conclusions
The proposed peer-support based self-management pro-
gram uses self-efficacy construct of Bandura’s Social
Cognitive Theory which is flexible and could potentially
be adapted in other chronic diseases. This intervention,
incorporating peers and telephone and text-messaging
approach will provide important information for future
research and care planning.
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